AIVA a New vasculitis organization in Italy

AIVA ODV Board

In July AIVA joined us at Vasculitis International. On Thursday july 26th 2024 this brand new vasculitis group was officially presented to the wider public, including the Italian parliament.  AIVA(Associazione Italiana Vasculiti ANCA) focuses on ANCA-associated forms of vasculitis and they want to bridge the information gap, enhance information and increase awareness of AAV at […]

Results ADVOCATE study in NEJM

tintrial

On February 18th 2021 the results of an important clinical study were published in the New England Journal of Medicine.   The trial was conducted from March 15, 2017, until November 1, 2019 (last trial visit).   In a phase 3 randomized trial (ADVOCATE) the avacopan product was compared with a tapering schedule of prednisone […]